The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Menarini International Operations Luxembourg S.A.EU/1/08/462/1,2,7,8

Main Information

Trade NameRanexa
Active SubstancesRanolazine
Dosage FormProlonged-release tablet
Licence HolderMenarini International Operations Luxembourg S.A.
Licence NumberEU/1/08/462/1,2,7,8

Group Information

ATC CodeC01EB Other cardiac preparations
C01EB18 ranolazine


License statusAuthorised
Licence Issued09/07/2008
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back